[Asia Economy Reporter Minwoo Lee] As the number of 'Wuhan pneumonia (novel coronavirus)' patients increases in China, countries around the world are on high alert. Amid this situation, the stock price of Naturecell, which has secured patents related to the treatment of the novel virus, is on the rise.
According to the Korea Exchange on the 22nd, as of 9:30 AM, Naturecell's stock price is at 6,690 won. This is about a 4% increase compared to the previous day. It has risen 13% in one month from the three-month low of 5,920 won recorded on December 17 last year.
It is interpreted that this is because Albaio (formerly R&L Bio), an affiliate of Naturecell, has secured patents for four new substances used in the development of novel flu treatments. Previously, Albaio filed international patents for four new substances extracted from alder trees, which have influenza treatment effects.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
